197A.T
TAUNS Laboratories,Inc.
スタンダード · 医薬品 · 医薬品 · JP
JPY 501.00
−0.99%Aug 20, 2026, 11:00 UTC
Towns announced a capital and business alliance with Taiwan's Asia Pathogenomics to collaborate on metagenomic next-generation sequencing for infectious diseases.
Aug 19, 2026, 06:01 UTC
Towns Co., Ltd. obtained manufacturing and marketing approval in July 2026 for the improved antigen test kit 'ImmunoAce SARS-CoV-2/Flu II' for medical institutions, which can detect both COVID-19 and influenza viruses from one nasal sample in about 10 minutes.
Source:Aug 19, 2026, 06:01 UTC
Towns Co., Ltd. announced its full-year results for the fiscal year ended June 2026, with net sales of 14,369 million yen (down 22.9% year-on-year) and operating profit of 4,200 million yen (down 49.2% year-on-year).
Source:Aug 18, 2026, 11:00 UTC
Towns participates as co-lead investor in Craif's Series D round totaling 5.3 billion yen.
Source:Jul 30, 2026, 09:59 UTC
Eiken Chemical announced on July 30, 2026, a partnership with Towns, a test kit distributor, to expand sales of Eiken's rapid test kits for streptococcus and adenovirus to clinics in Japan.
Source: